HuagongsheHuagongshe Chemistry Print Report · For research reference only
trans-3-(5-fluoro-1H-indol-3-yl)-cyclopentylamine → N-{[(2S)-8-ethoxy-2,3-dihydro-1,4-benzodioxin-2-yl]methyl}-N-[(trans)-3-(5-fluoro-1H-indol-3-yl)cyclopentyl]amine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | trans-3-(5-fluoro-1H-indol-3-yl)-cyclopentylamine | HCID 68827696 | — |
| Reactant | [(2R)-8-ethoxy-2,3-dihydro-benzo[1,4]dioxin-2-yl]methyl 4-methylbenzenesulfonate | HCID 86593209 | — |
| Product | N-{[(2S)-8-ethoxy-2,3-dihydro-1,4-benzodioxin-2-yl]methyl}-N-[(trans)-3-(5-fluoro-1H-indol-3-yl)cyclopentyl]amine | HCID 68827559 | 64% |
Reaction Steps
This compound was prepared in the same manner as for Example 1, using [(2R)-8-ethoxy-2,3-dihydro-benzo[1,4]dioxin-2-yl]methyl 4-methylbenzenesulfonate (0.25 g, 0.68 mmol) and trans-3-(5-fluoro-1H-indol-3-yl)-cyclopentylamine (0.3 g, 1.38 mmol) to afford 0.16 g (64%) of the title compound as its hydrochloride salt: MS (ESI) m/z 411 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07488751B2 |
| Source dataset | uspto-grants-2009_02 |
| ORD ID | ord-8e465a34c6994409a6163333c17739a3 |
| Source note | uspto-grants-2009_02 |